Hairy Cell Leukemia A Rare Case Report
Julian Dicki
—
ment, offering high rates of durable remission. Current Therapeutic Approaches Purine Nucleoside Analogues: Cladribine remains the frontline therapy, 1. achieving complete remission in over 80% of patients. Its administration is typically a single 5- to 7-day cour